Global Gene Therapy Market to Attain a CAGR of ~34% During 2022-2031; Market to Grow on Account of Increasing Prevalence of Cancer Cases and Ethical Acceptance of Gene Therapy for Cancer Treatment Kenneth Research published a report titled “Gene Therapy Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the gene therapy in terms of market segmentation by indication, technology, application, end user, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. Request
Sample
Report
:-
https://www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Increasing prevalence of cancer cases, and ethical acceptance of gene therapy for cancer treatment are driving the need to adopt gene therapies. For instance, according to the World Cancer Research Fund, the cancer cases all over the world were estimated to be 18.1 million in 2020, out of which, 9.3 million cases were in men and 8.8 million in women. These key factors are propelling the growth of the global gene therapy market, which is estimated to garner approximately USD 6 billion in revenue by 2031 by growing at a CAGR of nearly 34% over the forecast period, i.e., 2022 – 2031. The global market is segmented by indication into cancer, metabolic disorders, eye disorders, cardiovascular diseases, and others. Among these segments, the cancer segment is predicted to hold the largest share of the market attributed to increasing prevalence of several types of cancers. For instance, according to the World Cancer Research Fund, the most common cancers worldwide are breast and lung cancers, contributing 12.5% and 12.2%, respectively, of the total number of new cases diagnosed in 2020. Geographically, the global gene therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, the market in North America region is estimated to hold the largest share of the market and witness significant growth over the forecast period. The factors driving the market growth in the region are rapidly growing cancer cases. For instance, according to the Cancer
Facts & Figures report, as of 2021, the estimated number of new cancer cases diagnosed in the United States was 1.9 million. Additionally, Asia-Pacific is expected to witness the highest CAGR during the forecast period. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report. Request
Sample
Report
:-
https://www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Rising Awareness Regarding Benefits of Using Gene Therapy as Compared to Traditional Therapy for the Treatment of Various Diseases to Boost the Market Growth The rising awareness regarding benefits of using gene therapy as compared to traditional therapy for the treatment of various diseases is increasing the demand for gene therapies. This is a key factor that is anticipated to drive the growth of the market during the forecast period. Additionally, government support to promote gene therapy related research, and increase in funding for R&D activities are further expected to boost the market growth in upcoming years. However, high operational costs associated with gene therapy and unwanted immune responses are expected to operate as key restraints to the growth of the global gene therapy market over the forecast period. This report also provides the existing competitive scenario of some of the key players of the global gene therapy market which includes company profiling of Kineta, Inc., Novartis AG, Amgen Inc., bluebird bio, Inc., Gilead Sciences, Inc., Orchard Therapeutics plc, SIBIONO, Questex, CRISPR Therapeutics, Editas Medicine, and others.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global gene therapy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. Request
Sample
Report
:-
https://www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: sales@kennethresearch.com U.S. Phone: +1 313 462 0609